FDA Approves Expanded BHA Use With Stricter Regulations
Locales: Maryland, UNITED STATES

Washington, D.C. - The U.S. Food and Drug Administration (FDA) today announced a significant decision regarding Butylated Hydroxyanisole (BHA), a widely used preservative in both the food and cosmetics industries. After a comprehensive five-year review sparked by lingering safety concerns, the FDA has approved expanded use of BHA, contingent upon stricter regulations and a robust post-market surveillance program. The announcement, made on Wednesday, February 11th, 2026, is expected to impact a vast array of consumer products, from breakfast cereals and potato chips to lipsticks and moisturizers.
The decision stems from a 2021 report that re-ignited debate surrounding BHA's potential health risks, specifically concerning its possible carcinogenic effects. Initial studies in the 1970s and 80s linked high doses of BHA to tumor development in laboratory animals, prompting ongoing scrutiny and limited usage restrictions. The 2021 report, however, suggested that even lower, commonly encountered concentrations warranted further investigation. This triggered the FDA's extensive reevaluation, utilizing cutting-edge research methodologies and significantly larger sample sizes than previous assessments.
Dr. Eleanor Vance, the FDA's Chief Science Officer, emphasized the agency's cautious approach during a press conference. "The FDA's priority is, and always will be, public safety," she stated. "We undertook a painstaking review of all available data, including epidemiological studies, toxicological analyses, and exposure assessments. The new research allowed us to refine our understanding of BHA's metabolic pathways and to better model human exposure levels. What we found is that while BHA can exhibit carcinogenic properties under very specific and high-dose conditions in animals, the risk to humans at levels reasonably expected from typical consumption and cosmetic use is manageable - provided we implement and enforce stricter controls."
The new regulations, effective March 1st, 2026, focus on significantly lowering the maximum allowable concentrations of BHA in various food and cosmetic categories. The FDA is implementing a tiered system, with stricter limits for products intended for children and those with high consumption rates. Furthermore, the agency is mandating a comprehensive, ongoing post-market surveillance program. This program will involve continuous monitoring of consumer exposure levels, regular re-evaluation of the scientific literature, and the prompt investigation of any adverse health effects potentially linked to BHA.
Industry reaction has been largely positive. Representatives from the Food Manufacturers Association lauded the FDA's decision, arguing that BHA is a crucial ingredient for maintaining product quality, preventing rancidity, and extending shelf life - ultimately reducing food waste. They also highlighted the economic benefits of allowing continued, albeit regulated, use of the preservative. Cosmetic companies echoed these sentiments, emphasizing BHA's role in preventing oxidation and preserving the efficacy of their products.
However, consumer advocacy groups remain cautiously optimistic. Maria Rodriguez, Director of the Consumer Safety Alliance, acknowledged the FDA's thoroughness but stressed the need for vigilance. "We commend the FDA for undertaking this review and for incorporating more robust scientific evidence. However, the possibility of cumulative, long-term health effects from even low-level exposure to BHA remains a concern. We urge the FDA to maintain transparency and actively engage with independent researchers and consumer groups as the post-market surveillance program progresses." Rodriguez also called for increased funding for independent research into alternative preservatives.
The FDA's consumer guide, now available on its website [ https://www.fda.gov/bha-consumer-guide ], provides detailed information about BHA's properties, its uses, and the revised usage limits for different product categories. The guide also offers tips for consumers concerned about minimizing their exposure to BHA, such as reading product labels carefully and opting for products with natural preservatives when available.
This decision marks a turning point in the ongoing debate surrounding BHA. While not eliminating the concerns altogether, the FDA's revised regulations and robust monitoring program aim to strike a balance between preserving the benefits of this widely used preservative and safeguarding public health. The coming years will be critical in assessing the effectiveness of these measures and ensuring the long-term safety of products containing BHA.
Read the Full CNN Article at:
[ https://www.cnn.com/2026/02/10/health/fda-bha-preservative ]